Poland· PL-100507523
Griptavir Med
A oseltamivir product containing oseltamivirum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Oseltamivir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AH02 (oseltamivir), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Oseltamivir · ATC J05AH02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Oseltamivirum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- J05AH02
- ATC class
- Oseltamivir
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05904055006084
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
93 interactions on record for oseltamivir.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oseltamivir · interactions on record
93 records
- 4 moderate
- 1 minor
- 88 info
Most severe, free to view
- MethotrexateL01BA01moderate
- PemetrexedL01BA04moderate
- MethotrexateL04AX03moderate
- MethotrexatM01CX01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oseltamivir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesoseltamavir phosphateProficient Rx LP
- United KingdomEbilfumin 75mg capsulesTeva UK Ltd
- CanadaJAMP OSELTAMIVIRJAMP PHARMA CORPORATION
- SpainEBILFUMIN 75 MG CAPSULAS DURAS EFGActavis Group Ptc Ehf.
- NetherlandsEbilfumin 75 mg, harde capsuleActavis Group PTC ehf
- FinlandEbilfuminActavis Group PTC ehf
- CzechiaEBILFUMINActavis Group PTC ehf., Hafnarfjördur
- FranceEBILFUMIN 75 mg, géluleACTAVIS GROUP PTC (ISLANDE)
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Bulgaria · Бетафлу
- Germany · Oseltamivir Hec Pharm, Oseltamivir Stada
- Estonia · Segosana
- Spain · Oseltamivir Accord
- France · Oseltamivir Zentiva
- United Kingdom (Northern Ireland) · Oseltamivir, Oseltamivir Accord-Uk
- Hungary · Segosana
- Iceland · Ebilfumin, Tamiflu
- Liechtenstein · Ebilfumin, Tamiflu
- Lithuania · Segosana
- Latvia · Segosana
- Netherlands · Oseltamivir Zentiva, Segosana
- Norway · Ebilfumin, Tamiflu
- Romania · Oseltamivir Accord, Oseltamivir Laropharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa268050-6a1f-43fa-bd7f-9db2ccb891c9 GET /v1/drugs/fa268050-6a1f-43fa-bd7f-9db2ccb891c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "75 mg",
"packaging": "05904055006084 ¦ Rp ¦ 166071\n10 kaps.",
"substance": "Oseltamiviri phosphas -",
"common_name": "Oseltamivirum",
"pl_product_id": "100507523",
"pozwolenie_nr": "29506",
"auth_procedure": "NAR",
"authorisation_validity": "2031-03-09"
}See everything about oseltamivir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.